103 results
8-K
EX-10.1
CRBP
Corbus Pharmaceuticals Holdings Inc
10 Apr 24
Departure of Directors or Certain Officers
4:58pm
the term of his employment, the Executive will have access to the Company’s confidential business information (the “Confidential Information
8-K
EX-10.2
CRBP
Corbus Pharmaceuticals Holdings Inc
10 Apr 24
Departure of Directors or Certain Officers
4:58pm
as in effect from time to time.
CONFIDENTIALITY.
Definition. During the term of his employment, the Executive will have access to the Company’s
424B3
CRBP
Corbus Pharmaceuticals Holdings Inc
20 Mar 24
Prospectus supplement
5:07pm
and information statements, and other information regarding issuers, such as us, that file electronically with the SEC. Additionally, you may access
8-K
EX-1.1
3f1t9y7lm7qxu8p6roat
1 Feb 24
Corbus Pharmaceuticals Announces Proposed Public Offering
5:27pm
424B5
59449 1nbkzf6i53k
1 Feb 24
Prospectus supplement for primary offering
5:09pm
424B5
z2cv7za8s38w9gxcz5
31 Jan 24
Prospectus supplement for primary offering
12:00am
424B3
9esjrd bi99qtpjv
13 Jun 23
Prospectus supplement
4:58pm
8-K/A
EX-10.1
igo0by2rne5r
24 Apr 23
Departure of Directors or Certain Officers
4:39pm